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PREDICTIVE ANALYSIS OF MICROARRAY DATA
PAULO C. MARQUES F. AND CARLOS A. DE B. PEREIRA
Abstract. Microarray gene expression data are analyzed by means of a Bayesian
nonparametric model, with emphasis on prediction of future observables, yielding
a method for selection of differentially expressed genes and the corresponding clas-
sifier.
1. Introduction
DNA microarrays are devices used to determine the expression (activity level) of a
set of genes contained in a tissue sample. Briefly, they consist of small arrays of thou-
sands of probes on which surfaces are deposited many copies of single stranded DNAs
sequences corresponding to specific genes, or pieces of genes. Reverse transcription
of messenger RNAs extracted from the tissue produces a solution of DNAs whose
sequences are complementary to those found on the microarray probes. This solu-
tion is colored and put into contact with the microarray surface. Sequences present
in the solution hybridize with their complementary pairs on the microarray probes.
Subsequent illumination of the microarray surface provides an image in which the
intensity of each probe spot is related to the corresponding amount of messenger
RNAs present in the tissue. Digital processing of this image outputs for each probe
a positive number which measures the relative expression of the corresponding genes
(see [1] and references therein for a detailed description of microarray technology).
Data from a typical microarray experiment consist of positive numbers representing
the expression levels of the genes associated with the microarray probes for a group
of individuals. Because the convoluted nature of the numeric values describing the
expression levels makes it difficult to commit to a specific family of probability dis-
tributions in their modeling, our proposal is to approach this problem by means of a
Bayesian nonparametric analysis. The emphasis placed by De Finetti [2] on prediction
guides us, in the sense that both products of our analysis, a subset of differentially ex-
pressed genes and the corresponding classifier, are derived from probabilities of events
related to values of future observables, with (unobservable) parameters playing only
a subsidiary role.
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2. Microarray data model
Our microarray data consist of the expression levels of p gene probes for m case
patients that have been diagnosed with a certain disease or show some physiological
alteration, and n healthy control individuals. The expression level of the j-th mi-
croarray probe for the i-th case patient is denoted by Xji . Similarly, expression levels
for controls are denoted by Y ji . The expression levels of the p gene probes for the i-th
case patient are abbreviated by Xi = (X
1
i , . . . , X
p
i ). For controls, we define similarly
Yi = (Y
1
i , . . . , Y
p
i ).
The graph below depicts the microarray data model. Absence of an arrow con-
necting two random objects means that they are conditionally independent given
their parents. In this graph, the orphan vertexes are independent Dirichlet processes
distributed as Fj ∼ DP(cj, F
j
0 ) and Gj ∼ DP(dj, G
j
0), for gene probes j = 1, . . . , p.
Necessary Dirichlet process properties and notations are collected in the first appen-
dix.
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3. Predictive selection of differentially expressed genes
Suppose that we have microarray gene expression data for m case patients and
n healthy control individuals. Following the notations introduced in the previous
section and using the convention that upper case letters represent random variables
and small case letters their realizations, we denote this data by {xi}
m
i=1 and {yi}
n
i=1.
Our first goal is to use the information contained in this data to establish which
genes are expected to be less or more active for a future case patient, making these
differentially expressed genes a subset of disease markers.
For each gene probe, the relative expression of the corresponding gene can be
determined by our posterior opinion that for a future case patient the expression
level of this probe will be smaller than the expression level of the same probe for
a future healthy control individual, given all the information contained in the data.
This posterior opinion is quantified by the posterior predictive probabilities
qj = Pr
(
Xjm+1 ≤ Y
j
n+1 | {Xi = xi}
m
i=1, {Yi = yi}
n
i=1
)
,
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for gene probes j = 1, . . . p. Using the nonparametric data model of the previous
section, these posterior predictive probabilities can be computed using the results
given in the first appendix.
The values of these probabilities determine an ascending ranking of relative expres-
sion of the gene probes. We denote by X
(j)
i the expression level of the gene probe
occupying the j-th position in this ranking for the i-th case patient. To refer to the
gene probes at the end of the ranking, we use the notation X
(−j)
i = X
(p−j+1)
i . Similar
notations, Y
(j)
i and Y
(−j)
i , are used for healthy control individuals.
The criterion for the choice of the subset of differentially expressed genes is to
select from this ranking the first k (down regulated) gene probes and the last k (up
regulated) ones, for some integer k ≥ 1. In the last section we show how k can be
selected by cross validation.
4. Predictive classification
With the subset of 2k differentially expressed gene probes obtained in the previous
section, we construct a classification rule that allows us to pick microarray data for a
new individual and classify him as unhealthy or healthy. Let us denote case patients
and healthy controls together as
(Z1, . . . , Zm+n) = (X1, . . . , Xm, Y1, . . . , Yn) .
Defining the statistic T (Zi) =
∏k
j=1Z
(−j)
i /Z
(j)
i , which is an increasing function of
the expression level of the up regulated gene probes and a decreasing function of the
down regulated ones, we expect case patients to exhibit values for this statistic that
are larger than the corresponding values for healthy controls.
The classification rule is based on this one dimensional statistic and takes into
account the different sample sizes of the two groups, cases and controls. Given a new
individual for which we have microarray data zm+n+1, the rule is to classify him as
healthy when T (zm+n+1) is less than the critical value t
∗ for which
Pr
(
T (Zm+n+1) ≤ t
∗ | {Zi = zi}
m+n
i=1
)
=
n
m+ n
;
otherwise, we classify him as unhealthy. The critical value t∗ is computed using the
results given in the first appendix.
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Table 1. Gene probes and cross validation
Down regulated Up regulated Unhealthy Healthy
EBP GPR15 Case 100% 0%
EIF4B DDX3X Control 2.5% 97.5%
H3F3AP4 CBFB
MFSD11 SCAF11
5. Example
The publicly accessible Gene Expression Omnibus (GEO) database [3] provides
microarray data from a study [4] of peripheral circulating B cells for m = 39 smoking
and n = 40 non-smoking healthy american white women.
We proceed the analysis of this dataset using the results of the previous sections and
considering the case of weak prior information about the distribution of the expression
levels of the gene probes, which means that within the nonparametric model we
compute all the desired probabilities taking the limit to zero of the concentration
parameters of the Dirichlet processes.
Table 1 shows the identifiers for the k = 4 pairs of down and up regulated gene
probes computed for this dataset. This table also presents a leave one out cross
validated study of the sensitivity and specificity of the predictive classifier for this
dataset using the k = 4 pairs of down and up regulated gene probes. For this dataset,
k = 4 is the smallest number of pairs of up and down regulated gene probes that
gives us the best balance between cross validated fractions of false negatives and
false positives. Computer code in the Perl language [5] is presented in the second
appendix.
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Appendix 1: The Dirichlet process
We are concerned with the representation of our uncertainties about some observ-
able properties assuming values in a sampling space X , with sigma-field A , by means
of a probability measure defined over an underlying measurable space (Ω,F ). The
probability of an event B ∈ F is denoted by Pr(B).
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The map Q : A × Ω → [0, 1] is a random probability measure over (X ,A ) if
Q( · , ω) is a probability measure over this measurable space for every ω ∈ Ω, and
Q(A) = Q(A, · ) is a random variable for each A ∈ A .
Ferguson [6] defined a random probability measure Q as follows. Let α be a finite
nonzero measure over (X ,A ) and specify that for each A -measurable partition
{A1, . . . , Ak} of X the random vector
(Q(A1), . . . , Q(Ak))
has the usual Dirichlet distribution with parameters (α(A1), . . . , α(Ak)). One such
Q is denominated a Dirichlet process with base measure α.
Ferguson proved that this definition entails the following facts. First, Q is a prop-
erly defined random process in the sense of Kolmogorov’s consistency theorem [7].
Second, the expectation of Q has the simple expression E[Q(A)] = α(A)/α(X ), for
each A ∈ A . Third, if measurable observables Xi : Ω → X are conditionally in-
dependent and identically distributed, given Q, with Pr(Xi ∈ A | Q) = Q(A) almost
surely, for i = 1, . . . , m, then a posteriori Q is again a Dirichlet process with base
measure β defined almost surely by β(A) = α(A) +
∑m
i=1 IA(Xi), for each A ∈ A .
If we add a new observable Xm+1 to the just described conditional model, its
posterior predictive probability is
Pr(Xm+1 ∈ A | {Xi}
m
i=1) = E[Pr(Xm+1 ∈ A | Q, {Xi}
m
i=1) | {Xi}
m
i=1]
= E[Pr(Xm+1 ∈ A | Q) | {Xi}
m
i=1]
= E[Q(A) | {Xi}
m
i=1] ,
almost surely, for every A ∈ A , in which the second equality follows from the condi-
tional independence of the observables.
For microarray data the sampling space can be taken as the real line with Borel
sigma-field. If Q is a Dirichlet process with base measure α, it is convenient to
work with the random distribution function defined by F (t, ω) = Q((−∞, t], ω). We
abbreviate F (t) = F (t, · ). Defining c = α(R) and F0(t) = α(−∞, t]/α(R), we
denote the distribution of the random distribution function by F ∼ DP(c, F0). Since
β(R) = c+ n, the posterior expectation of F is almost surely
Fˆ0,m(t) = E[F (t) | {Xi}
m
i=1] =
c
c+m
F0(t) +
m
c+m
Fˆm(t) ,
in which Fˆm(t) = (1/m)
∑m
i=1 I[Xi,∞)(t) is the empirical distribution function. This
gives us an interpretation of the base measure of the Dirichlet process. The total
measure c works as a concentration parameter: for fixed sample size m, if we make
c ↓ 0, the posterior expectation reduces to the empirical distribution function. Also,
this expression of Fˆ0,m shows that prior information contained in F0 is washed out
when, for fixed c, we let m→∞.
6 MARQUES AND PEREIRA
Finally, suppose that we have a second sample: let Y1, . . . , Yn, Yn+1 be conditionally
independent and identically distributed, given G, each one of them having conditional
distribution G, and G ∼ DP(d,G0) is independent of F . The posterior expectation
is almost surely
Gˆ0,n(t) = E[G(t) | {Yi}
n
i=1] =
d
d+ n
G0(t) +
n
d+ n
Gˆn(t) ,
in which Gˆn(t) = (1/n)
∑n
i=1 I[Yi,∞)(t). If U and V are independent random variables
with distribution functions FU and FV , respectively, a simple computation shows that
Pr(U ≤ V ) =
∫
∞
−∞
FU(t) dFV (t). Therefore, since Xm+1 and Yn+1 are conditionally
independent, given {Xi}
m
i=1 and {Yi}
n
i=1, and almost surely
Xm+1 | {Xi}
m
i=1 ∼ Fˆ0,m , Yn+1 | {Yi}
n
i=1 ∼ Gˆ0,n ,
it follows that almost surely
Pr(Xm+1 ≤ Yn+1 | {Xi}
m
i=1, {Yi}
n
i=1) =
∫
∞
−∞
Fˆ0,m(t) dGˆ0,n(t) .
If we let c, d ↓ 0, this conditional probability reduces to
1
mn
m∑
i=1
n∑
j=1
I[Xi,∞)(Yj) .
Appendix 2: Computer code
#!/usr/bin/perl
# predictive.pl - <pmarques@ime.usp.br>
use strict;
use warnings;
my $k = 4;
print "\nSelecting k = $k pairs of Down / Up regulated gene probes.\n\n";
my @cases = (42..80);
my @controls = (2..41);
my @all = (@cases, @controls);
my $ua;
open(DATA, "./GDS3713.soft") or die $!;
while (<DATA>) {
next unless $. >= 118 && $. <= 22400;
chomp;
push @$ua, [ split(/\t/, $_) ];
}
close(DATA);
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my @pr;
foreach my $probe (@$ua) {
push @pr, pr_next_case_leq_next_control($probe, \@cases, \@controls);
}
my @ranking = sort { $pr[$b] <=> $pr[$a] } (0 .. @$ua - 1);
print "Down regulated | Up regulated\n";
print "---------------+--------------\n";
for (my $i = 0; $i < $k; $i++) {
printf("%-14s | %-13s\n",
$ua->[$ranking[$i]]->[1], $ua->[$ranking[-($i + 1)]]->[1]);
}
print "\n";
printf("Critical t = %.4f\n\n",
critical_t($ua, \@ranking, $k, scalar @controls, \@all));
print "Cross validated sensitivity and specificity.\n\n";
my ($case_unhealthy, $case_healthy,
$control_unhealthy, $control_healthy) = (0, 0, 0, 0);
foreach my $group (\@cases, \@controls) {
foreach my $off (@$group) {
my $s = T_statistic($ua, \@ranking, $k, $off);
my @T;
foreach my $individual (@all) {
next if $individual == $off;
push @T, T_statistic($ua, \@ranking, $k, $individual);
}
@T = sort { $a <=> $b } @T;
if ($group == \@cases) {
if ($s <= $T[@controls - 1]) { $case_healthy++ }
else { $case_unhealthy++ }
} else {
if ($s <= $T[@controls - 2]) { $control_healthy++ }
else { $control_unhealthy++ }
}
}
}
print "-" x 29, "\n Unhealthy | Healthy\n";
print "-------------------+---------\n";
printf(" Case %.4f | %.4f\n",
$case_unhealthy / @cases, $case_healthy / @cases);
print "-" x 29, "\n";
printf(" Control %.4f | %.4f\n",
$control_unhealthy / @controls, $control_healthy / @controls);
print "-" x 29, "\n";
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exit 1;
sub pr_next_case_leq_next_control {
my ($probe, $cases, $controls) = @_;
my $leq = 0;
foreach my $case (@$cases) {
foreach my $control (@$controls) {
$leq++ if $probe->[$case] <= $probe->[$control];
}
}
return $leq / (@$cases * @$controls);
}
sub T_statistic {
my ($ua, $ranking, $k, $individual) = @_;
my $t = 1;
for (my $i = 0; $i < $k; $i++) {
$t *= $ua->[$ranking->[-($i + 1)]]->[$individual];
$t /= $ua->[$ranking->[$i]]->[$individual];
}
return $t;
}
sub critical_t {
my ($ua, $ranking, $k, $n, $all) = @_;
my @T;
foreach my $individual (@$all) {
push @T, T_statistic($ua, $ranking, $k, $individual);
}
@T = sort { $a <=> $b } @T;
return $T[$n - 1];
}
References
[1] Friend, S. H. and Stoughton, R. B. (2002) The Magic of Microarrays. Scientific American,
286(2), 34–41.
[2] De Finetti, B. (1974) Theory of Probability (two volumes). John Wiley & Sons.
[3] GEO dataset GDS3713. http://www.ncbi.nlm.nih.gov/geo/
[4] Pan F., Yang T. L., Chen X. D., Chen Y., Gao G., Liu Y. Z., Pei Y. F., Sha B. Y., Jiang Y.,
Xu C., Recker R. R and Deng H. W (2010) Impact of female cigarette smoking on circulating
B cells in vivo: the suppressed ICOSLG, TCF3, and VCAM1 gene functional network may
inhibit normal cell function. Immunogenetics, 62(4), 237–251.
[5] Wall, L., Christiansen, T. and Orwant, J. (2000) Programming Perl. 3rd Edition. O’Reilly
Media.
[6] Ferguson T. (1972) A Bayesian Analysis of Some Nonparametric Problems. The Annals of
Statistics, 1, 209–230.
[7] Schervish, M. J. (1997) Theory of Statistics. Springer-Verlag.
Instituto de Matema´tica e Estat´ıstica da Universidade de Sa˜o Paulo
E-mail address : pmarques@ime.usp.br
